The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis

利培酮 氟哌啶醇 心理学 敌意 锥体外系症状 阳性与阴性症状量表 精神分裂症(面向对象编程) 安慰剂 抗精神病药 焦虑 内科学 精神科 多巴胺拮抗剂 精神病 医学 临床心理学 多巴胺 替代医学 病理
作者
S.R. Marder,John M. Davis,Guy Chouinard
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:58 (12): 538-546 被引量:698
标识
DOI:10.4088/jcp.v58n1205
摘要

Article AbstractBackground: In two double-blind trials conducted in North America, 513 patients with chronic schizophrenia received risperidone, haloperidol, or placebo. In the present study, combined data from the two trials were analyzed. Method: Patients were randomly assigned to receive placebo, fixed doses of risperidone (2, 6, 10, and 16 mg/day), or 20 mg/day of haloperidol for 8 weeks. Factor analysis of scores on the Positive and Negative Syndrome Scale (PANSS) produced five dimensions (negative symptoms, positive symptoms, disorganized thought, uncontrolled hostility/excitement, and anxiety/depression), similar to the five dimensions of previous factor-analytic studies of PANSS data.Results: Mean changes (symptom reductions) in PANSS factor scores from baseline to treatment Weeks 6 and 8 were significantly greater in patients receiving 6_16 mg/day of risperidone than in patients receiving placebo or haloperidol. The advantages of risperidone were greatest for negative symptoms, uncontrolled hostility/excitement, and anxiety/depression. Even at the lowest dose, 2 mg/day, risperidone was significantly (pÐ.05) superior to haloperidol in reducing negative symptoms. The differences in outcomes between risperidone and haloperidol on PANSS scores were not related to extrapyramidal symptoms.Conclusion: Risperidone produced significantly (pÐ.05) greater improvements than haloperidol on all five dimensions. The large between-group differences on negative symptoms, hostility/excitement, and anxiety/depression suggest that risperidone and other serotonin/dopamine antagonists have qualitatively different effects from those of conventional antipsychotic agents.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
放肆青春发布了新的文献求助10
刚刚
桂花酒酿发布了新的文献求助10
1秒前
11111111111发布了新的文献求助10
2秒前
丘比特应助Fancy采纳,获得10
2秒前
小二郎应助高高ai采纳,获得10
2秒前
饼饼完成签到 ,获得积分10
2秒前
2秒前
3秒前
YANGLan发布了新的文献求助10
3秒前
BK2008发布了新的文献求助10
4秒前
FashionBoy应助一原君采纳,获得10
4秒前
4秒前
5秒前
翊瑾发布了新的文献求助10
6秒前
6秒前
研友_n2B1qn完成签到,获得积分10
6秒前
Luke发布了新的文献求助10
7秒前
思源应助zj采纳,获得10
7秒前
7秒前
8秒前
wonhui发布了新的文献求助10
9秒前
MaFY完成签到,获得积分10
9秒前
qy完成签到,获得积分10
9秒前
畅快的刚完成签到,获得积分10
9秒前
FashionBoy应助哈哈哈采纳,获得10
9秒前
9秒前
隐形曼青应助Ran采纳,获得10
10秒前
苏书白应助梅子采纳,获得10
10秒前
xuxu发布了新的文献求助20
10秒前
浩浩发布了新的文献求助10
10秒前
11秒前
12秒前
大方思柔发布了新的文献求助10
13秒前
万能图书馆应助zt采纳,获得10
13秒前
维拉帕米橘子完成签到,获得积分10
13秒前
都能进发布了新的文献求助10
14秒前
16秒前
上官若男应助Luke采纳,获得10
17秒前
满满阳光发布了新的文献求助100
17秒前
Marco完成签到 ,获得积分10
18秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
Classics in Total Synthesis IV 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3150027
求助须知:如何正确求助?哪些是违规求助? 2801108
关于积分的说明 7843272
捐赠科研通 2458621
什么是DOI,文献DOI怎么找? 1308555
科研通“疑难数据库(出版商)”最低求助积分说明 628553
版权声明 601721